FBP1 is recognised as the key enzyme of gluconeogenesis, and upregulated FBP1 has been shown to suppress cancer cell growth [12,13]; recent studies indicate that FBP2 participates in glycogen synthesis from carbohydrate precursors [14]. The gene discussed is FBP2; the disease is cancer.